Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure: How to Select the Right Candidate?

[1]  G. Lippi,et al.  Global epidemiology and future trends of heart failure , 2020 .

[2]  D. Burkhoff,et al.  Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System , 2020, Circulation. Heart failure.

[3]  W. Abraham,et al.  Optimizer smart in the treatment of moderate-to-severe chronic heart failure. , 2019, Future cardiology.

[4]  D. Burkhoff,et al.  Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond , 2018, European journal of heart failure.

[5]  N. Hawkins,et al.  Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure , 2018, ESC heart failure.

[6]  D. Burkhoff,et al.  A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. , 2018, JACC. Heart failure.

[7]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[8]  T. Lawo,et al.  Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. , 2016, International journal of cardiology.

[9]  D. Burkhoff,et al.  Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients. , 2015, International journal of cardiology.

[10]  Daniel P. Morin,et al.  Cardiac resynchronization therapy: history, present status, and future directions. , 2014, The Ochsner journal.

[11]  F. Prinzen,et al.  Cardiac Resynchronization Therapy: State-of-the-Art of Current Applications, Guidelines, Ongoing Trials, and Areas of Controversy , 2013, Circulation.

[12]  Jeroen J. Bax,et al.  Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2013, The New England journal of medicine.

[13]  D. Burkhoff,et al.  Cardiac contractility modulation in patients with advanced heart failure , 2013, Expert review of cardiovascular therapy.

[14]  D. Burkhoff,et al.  Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, Journal of cardiac failure.

[15]  Paul J. Wang,et al.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[16]  D. Burkhoff,et al.  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, American heart journal.

[17]  J. Healey,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[18]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[19]  M. Gold,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[20]  D. Burkhoff,et al.  Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. , 2008, Journal of the American College of Cardiology.

[21]  G. Hindricks,et al.  Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. , 2008, European heart journal.

[22]  D. Burkhoff,et al.  Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. , 2007, Journal of the American College of Cardiology.

[23]  E. Wellnhofer,et al.  Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. , 2007, Journal of cardiac failure.

[24]  D. Burkhoff,et al.  Cardiac contractility modulation by non‐excitatory currents: Studies in isolated cardiac muscle , 2006, European journal of heart failure.

[25]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[26]  Nick Freemantle,et al.  The impact of chronic heart failure on health‐related quality of life data acquired in the baseline phase of the CARE‐HF study , 2005, European journal of heart failure.

[27]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[28]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[29]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[30]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[31]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[32]  W. Abraham,et al.  Book Review Cardiac Resynchronization Therapy in Heart Failure , 2011 .